Pharmacological and functional characterization of bradykinin B 2 receptor in human prostate

European Journal of Pharmacology

Volumn 504, Issue 3, 2004, Pages 155-167

  Srinivasan, Dinesh ^a   Kosaka, Alan H ^a   Daniels, Donald V ^a   Ford, Anthony P D W ^a   Bhattacharya, Anindya ^a  

^a ROCHE BIOSCIENCE   (United States)

Author keywords

Bradykinin; Human; prostate; Prostate epithelial cell; Prostate stromal cell

Indexed keywords

BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; ICATIBANT; INOSITOL PHOSPHATE; KALLIDIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1;

ADOLESCENT; ADULT; ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CARCINOMA CELL; CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; RECEPTOR AFFINITY; STROMA CELL;

ADOLESCENT; ADULT; BLOTTING, WESTERN; CALCIUM; CELL LINE, TUMOR; CELL PROLIFERATION; COLORIMETRY; ENZYME ACTIVATION; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMUNOHISTOCHEMISTRY; INOSITOL PHOSPHATES; MALE; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 8444231324     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.10.004     Document Type: Article

References (47)

1. R. Altamura, S. Meini, L. Quartara, and C.A. Maggi Nonpeptide antagonists for kinin receptors Regul. Pept. 80 1999 13 26
2. O. Arunalakshana, and H.O. Schild Some quantitative uses of drug antagonists Br. J. Pharmacol. 14 1959 48 58
3. K. Baba, and O. Yamaguchi Effects of bradykinin on cytoplasmic calcium and motility in murine bladder tumor cells J. Urol. 165 2001 259 262
4. L. Barki-Harrington, and Y. Daaka Bradykinin induced mitogenesis of androgen independent prostate cancer cells J. Urol. 165 2001 2121 2125
5. L. Barki-Harrington, A.L. Bookout, G.F. Wang, M.E. Lamb, L.M.F. Leeb-Lundberg, and Y. Daaka Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells Biochem. J. 371 2003 581 587
6. P. Belichard, J.M. Luccarini, E. Defrene, P. Faye, R.M. Franck, H. Duclos, J.L. Paquet, and D. Pruneau Pharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide-treated rats Br. J. Pharmacol. 128 1999 213 219
7. M.V. Berridge, and A.S. Tan Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction Arch. Biochem. Biophys. 303 1993 474 482
8. A. Blaukat Structure and signaling pathways of kinin receptors Andrologia 35 2003 17 23
9. C. Boselli, S. Govoni, D. Vicini, C. Lanni, M. Racchi, and G. D'Agostino Presence and passage dependent loss of biochemical M3 muscarinic receptor function in human detrusor cultured smooth muscle cells J. Urol. 168 2002 2672 2676
10. P.E. Brandish, L.A. Hill, W. Zheng, and E.M. Scolnick Scintillation proximity assay of inositol phosphates in cell extracts: high-throughput measurement of G-protein-coupled receptor activation Anal. Biochem. 313 2003 311 318
11. S.K. Butt, L.G. Dawson, and J.M. Hall Bradykinin B1 receptors in the rabbit urinary bladder-induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis Br. J. Pharmacol. 114 1995 612 617
12. D.J. Campbell The renin-angiotensin and the kallikrein-kinin systems Int. J. Biochem. Cell Biol. 35 2003 784 791
13. M.C. Charlesworth, C.Y. Young, V.M. Miller, and D.J. Tindall Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid J. Androl. 20 1999 220 229
14. Z.J. Chen, M. Vetter, D.N. Che, S.G. Liu, M.L. Tsai, and C.H. Chang The bradykinin/soluble guanylate cyclase signaling pathway is impaired in androgen-independent prostate cancer cells Cancer Lett. 177 2002 181 187
15. Y. Daaka Mitogenic action of LPA in prostate Biochim. Biophys. Acta 1582 2002 265 269
16. C. Davis, and G. Burgess The pharmacology of T-kinin and des-Arg(11)-T-kinin in primary cultures of rat bladder smooth muscle cells Eur. J. Pharmacol. 450 2002 123 130
17. 2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal ischemia Br. J. Pharmacol. 139 2003 1539 1547
18. N. Fukushima, and J. Chun The LPA receptors Prostaglandins Other Lipid Mediat. 64 2001 21 32
19. S.W. Hayward, R. Dahiya, G.R. Cunha, J. Bartek, N. Deshpande, and P. Narayan Establishment and characterization of an immortalized but non transformed human prostate epithelial cell line: Bph-1 In Vitro Cell. Dev. Anim. 31 1995 14 24
20. J.F. Hess, J.A. Borkowski, G.S. Young, C.D. Strader, and R.W. Ransom Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor Biochem. Biophys. Res. Commun. 184 1992 260 268
21. Y. Hirayama, K. Miyayasu, K. Yamagami, T. Imai, Y. Ohkubo, and S. Mutoh Effect of FK3657, a non-peptide bradykinin B2 receptor antagonist, on allergic airway disease models Eur. J. Pharmacol. 467 2003 197 203
22. J. Howl, and S.J. Payne Bradykinin receptors as a therapeutic target Expert Opin. Ther. Targets 7 2003 277 285
23. K. Jarnagin, S. Bhakta, P. Zuppan, C. Yee, T. Ho, T. Phan, R. Tahilramani, J.H.B. Pease, A. Miller, and R. Freedman Mutations in the B2 bradykinin receptor reveal a different pattern of contacts for peptide agonists and peptide antagonists J. Biol. Chem. 271 1996 28277 28286
24. T.P. Kenakin Antagonism Pharmacological Analysis of Drug-Receptor Interaction third edition 1997 Lippincott-Raven Press Publishers Philadelphia 374 395
25. A. Kooistra, N.M.J. Elissen, J.J. Konig, M. Vermey, T.H. Vanderkwast, J.C. Romijn, and F.H. Schroder Immunocytochemical characterization of explant cultures of human prostatic stromal cells Prostate 27 1995 42 49
26. A. Lecci, S. Giuliani, S. Meini, and C.A. Maggi Pharmacological analysis of the local and reflex responses to bradykinin on rat urinary bladder motility in vivo Br. J. Pharmacol. 114 1995 708 714
27. A. Lecci, S. Meini, M. Tramontana, S. Giuliani, M. Criscuoli, and C.A. Maggi Kinin B1 receptor-mediated motor responses in normal or inflamed rat urinary bladder in vivo Regul. Pept. 80 1999 41 47
28. S. Meini, R. Patacchini, S. Giuliani, M. Lazzeri, D. Turini, C.A. Maggi, and A. Lecci Characterization of bradykinin B2 receptor antagonists in human and rat urinary bladder Eur. J. Pharmacol. 388 2000 177 182
29. J.G. Menke, J.A. Borkowski, K.K. Bierilo, T. Macneil, A.W. Derrick, K.A. Schneck, R.W. Ransom, C.D. Strader, D.L. Linemeyer, and J.F. Hess Expression cloning of a human B1 bradykinin receptor J. Biol. Chem. 269 1994 21583 21586
30. M.C. Nowycky, and A.P. Thomas Intracellular calcium signaling J. Cell. Sci. 115 2002 3715 3716
31. B.A. O'Reilly, A.H. Kosaka, G.F. Knight, T.K. Chang, A.P.D.W. Ford, J.M. Rymer, R. Popert, G. Burnstock, and S.B. McMahon P2X receptors and their role in female idiopathic detrusor instability J. Urol. 167 2002 157 164
32. 1 agonist occurs through independent and synergistic intracellular signaling mechanisms in human lung fibroblasts J. Pharmacol. Exp. Ther. 298 2001 77 85
33. A. Rosamilla, J.A. Clements, P.L. Dwyer, M. Kende, and D.J. Campbell Activation of the kallikrein kinin system in interstitial cystitis J. Urol. 162 1999 129 134
34. W.B. Schill, and W. Miska Possible effects of the kallikrein-kinin system on male reproductive functions Andrologia 24 1992 69 75
35. A. Scorilas, M. Plebani, S. Mazza, D. Brasso, A.R. Soosaipillai, N. Katsaros, F. Pagano, and E.P. Diamandis Serum human glandular kallikrein (hK2) and insulin-like growth factor I (IGF-I) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA Prostate 54 2003 220 229
36. P.B. Simpson, A.J. Woollacott, R.G. Hill, and G.R. Seabrook Functional characterization of bradykinin analogues on recombinant human bradykinin B1 and B2 receptors Eur. J. Pharmacol. 392 2000 1 9
37. D. Srinivasan, L.R. Burbach, D.V. Daniels, A.P.D.W. Ford, and A. Bhattacharya Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate Br. J. Pharmacol. 142 2004 297 304
38. C.P. Steidle, M.L. Cohen, and B.L. Neubauer Bradykinin-induced contractions of canine prostate and bladder: effect of angiotensin-converting enzyme inhibition J. Urol. 144 1990 390 392
39. C. Stephan, G.M. Yousef, A. Scorilas, K. Jung, M. Jung, G. Kristiansen, S. Hauptmann, B.S. Bharaj, T. Nakamura, S.A. Loening, and E.P. Diamandis Quantitative analysis of kallikrein 15 gene expression in prostate tissue J. Urol. 169 2003 361 364
40. J.M. Stewart, D.C. Chan, V. Simkeviciene, P.A. Bunn, B. Helfrich, E.J. York, L. Taraseviciene-Stewart, D. Bironaite, and L. Gera Bradykinin antagonists as new drugs for prostate cancer Int. Immunopharmacol. 2 2002 1781 1786
41. 2+] using the fluorometric imaging plate reader (FLIPR) Methods Mol. Biol. 114 1999 125 133
42. J.S. Taub, R. Guo, L.M.F. Leeb-Lundberg, J.F. Madden, and Y. Daaka Bradykinin receptor subtype 1 expression and function in prostate cancer Cancer Res. 63 2003 2037 2041
43. P.D. Walden, G.K. Lefkowitz, M. Ittmann, H. Lepor, and M.E. Monaco Mitogenic activation of human prostate-derived fibromuscular stromal cells by bradykinin Br. J. Pharmacol. 127 1999 220 226
44. K. Wirth, G. Breipohl, J. Stechl, J. Knolle, S. Henke, and B. Scholkens DesArg9-d-Arg(Hyp3, Thi5, d-Tic7, Oic8)bradykinin (desArg10-(Hoe140)) is a potent bradykinin B1 receptor antagonist Eur. J. Pharmacol. 205 1991 217 218
45. K. Wirth, F.J. Hock, U. Albus, W. Linz, H.G. Alpermann, H. Anagnastopulos, S. Henke, G. Breipohl, W. Konig, J. Knolle, and B. Scholkens Icatibant, a new potent and long-acting bradykinin antagonist: in-vivo studies Br. J. Pharmacol. 102 1991 774 777
46. M.R. Wood, J.J. Kim, W. Han, B.D. Dorsey, C.F. Homnick, R.M. DiPardo, S.D. Kuduk, T. MacNeil, K.L. Murphy, E.V. Lis, R.W. Ransom, G.L. Stump, J.J. Lynch, S.S. O'Malley, P.J. Miller, T.B. Chen, C.M. Harrell, R.S.L. Chang, P. Sandhu, J.D. Ellis, P.J. Bondiskey, D.J. Pettibone, R.M. Freidinger, and M.G. Bock Benzodiazepines as potent and selective bradykinin B1 antagonists J. Med. Chem. 46 2003 1803 1806
47. G.M. Yousef, C. Stephan, A. Scorilas, M.A. Ellatif, K. Jung, G. Kristiansen, M. Jung, M.E. Polymeris, and E.P. Diamandis Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues Prostate 56 2003 287 292